Aswe, Elizer R.
HRN: 14-53-45 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/23/2024
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
08/23/2024
08/26/2024
IV
500mg
Q6H
Hepatic Abscess
Waiting Final Action
Indication: Empirical De-escalation Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes